Previous 10 | Next 10 |
NEW YORK, Feb. 01, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of Exelixis, Inc. (NASDAQ:EXEL), Varian Medical Systems, Inc. (NYSE:VAR), DXC Tec...
Today's Top Stories: All eyes on Draghi's Eurozone risk outlook; China adds gold to help cut dollar dependence; and Apple self-driving car initiative sheds 200 employees. If you are interested in listening to Wall Street Breakfast to start your day, look for us in the following places...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on iTunes , Stitcher and SoundCloud (click the highlighted links). With no new actions expected at the European Central Bank's policy meeting today, investors will focus on Mario Dr...
The following slide deck was published by Varian Medical Systems, Inc. in conjunction with their 2019 Q1 earnings Read more ...
Varian Medical Systems, Inc. (VAR) Q1 2019 Earnings Conference Call January 23, 2019 4:30 PM ET Company Participants Michael Bruff - SVP, IR Dow Wilson - President and CEO Gary Bischoping - CFO Conference Call Participants Matt Taylor - UBS Amit Hazan - Citigroup Anthon...
Varian (NYSE: VAR ) fiscal Q1 results ($M): Revenues: 741.0 (+9.2%). More news on: Varian Medical Systems, Inc., Healthcare stocks news, Earnings news and commentary, Read more ...
Varian Medical Systems (NYSE: VAR ): Q1 Non-GAAP EPS of $1.06 misses by $0.01 ; GAAP EPS of $1.12 beats by $0.15 . More news on: Varian Medical Systems, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
PALO ALTO, Calif. , Jan. 23, 2019 /PRNewswire/ -- First Quarter 2019 Summary – Oncology gross orders grew 16% in dollars, or 17% in constant currency – Total company revenues grew 9% in dollars, or...
News, Short Squeeze, Breakout and More Instantly...
Varian Medical Systems Inc. Company Name:
VAR Stock Symbol:
NYSE Market:
Varian Medical Systems Inc. Website:
Varian Announces First Participant Treated in GENESIS II Clinical Trial of Genicular Artery Embolization for Knee Osteoarthritis PR Newswire PALO ALTO, Calif. , Nov. 17, 2022 /PRNewswire/ -- Varian, a Siemens Healthineers company, announced today that the...
Varian and the Cincinnati Children's/University of Cincinnati Medical Center Proton Therapy Center Announce Promising Results from FAST-01, First-in-Human Clinical Trial of Flash Therapy PR Newswire – Results published in JAMA Oncology and presented at ASTRO dem...